Dark

SNY
Sanofi
stock NASDAQ ADR

At Close

May 8, 2025 3:59:49 PM EDT

52.15USD-0.230%(-0.12)1,886,538

0.00Bid 0.00Ask 0.00Spread

Pre-market

May 8, 2025 9:15:30 AM EDT

52.18USD-0.172%(-0.09)1,872

After-hours

May 8, 2025 4:00:30 PM EDT

52.13USD+0.038%(+0.02)1,881

OverviewOptionsHistoricalExchangesShortsNews

Jan 31, 2022

06:45AM EST CHMP Backs Sanofi-Regeneron's Dupixent For Asthma Patients Aged 6 - 11 Years With Type 2 Inflammation Benzinga

05:47AM EST European Medicines Agency's Committee for Medicinal Products for Human Use Recommended Approval of Dupixent for Children Aged 6 to 11 Years with Severe Asthma with Type 2 Inflammation Benzinga

01:02AM EST Sanofi :CHMP Recommends Approval Of Dupixent For Children Aged 6 To 11 Yrs With Severe Asthma With Type 2 Inflammation RTTNews

Jan 28, 2022

10:32AM EST Regeneron, Sanofi Withdraw FDA Application For Libtayo's Expanded Use Benzinga

08:21AM EST The Daily Biotech Pulse: Biogen Liquidates Out Of Biosimilar JV, Provention Bio Plots Diabetes Drug Resubmission, Merck Finds COVID Pill Effective Against Omicron Benzinga

07:03AM EST Regeneron And Sanofi Provide Regulatory Update On Libtayo In Advanced Cervical Cancer Benzinga

07:03AM EST Regeneron And Sanofi Announce Voluntary Withdrawal Of SBLA For Libtayo In Advanced Cervical Cancer RTTNews

Jan 19, 2022

09:29AM EST Second Dupixent Phase 3 Trial Confirms Significant Improvements In Inflammatory Skin Disease Benzinga

01:02AM EST Regeneron And Sanofi Say Phase 3 Dupixent Trial Confirms Significant Improvements For Patients With Prurigo Nodularis RTTNews

Jan 13, 2022

12:55PM EST Connect Biopharma's Latest Dermatitis Drug Update Fails to Pump Up Shares Benzinga

Jan 7, 2022

01:01PM EST Exscientia and Sanofi Announced Strategic Research Collaboration to Develop AI-driven Pipeline of Precision-engineered Medicines Exscientia to Receive Upfront Cash Payment of $100M From Sanofi Plus Up to $5.2B in Milestone, Regulatory Payments Benzinga

Jan 6, 2022

06:59AM EST Sangamo Therapeutics Announces Sanofi Notified Co. Of Its Termination Of Collaboration Agreement, Effective June 28, 2022 Benzinga

Dec 21, 2021

08:12AM EST The Daily Biotech Pulse: Aldeyra Sinks On Dry Eye Disease Readout, Sanofi Goes Shopping, Regulatory Setback For Aquestive, Aridis Touts Pan-Coronavirus Antibody Cocktail Benzinga

07:01AM EST Sanofi Agrees To Buy US-Based Amunix Pharma For $1B Upfront Benzinga

Dec 20, 2021

12:34PM EST President Biden Tweets 'Right now, there's a kid out there whose family can't afford her insulin because it costs $1,000 per month. The Build Back Better Act would cap their monthly insulin costs at $35. I'm committed as ever to getting it done for them.' Benzinga

Dec 15, 2021

11:13AM EST Sanofi, Glaxo's COVID-19 Vaccine Candidate Works As Booster, But Data Readout Pushed Back Benzinga

08:03AM EST The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO Benzinga

04:59AM EST Sanofi, GlaxoSmithKline Said They Expect Data from Late-stage Clinical Trials of its Booster Dose of Their Covid-19 Vaccine Candidate in Q1 2022 vs Late 2021 Benzinga

Dec 14, 2021

12:48PM EST Sanofi Reveals Late-Stage Data For Fitusiran In Hemophilia Patients Benzinga

Dec 13, 2021

01:03PM EST Regeneron, Sanofi Early Monday Announced Phase 3 Dupixent Data In Children 6 Months To 5 Years For Moderate-To-Severe Atopic Dermatitis Showed Improvement In Skin Clearance, Reduced Disease Severity Benzinga

12:12PM EST Comparing Data: Sanofi Vs. Johnson & Johnson Multiple Myeloma Therapies In Newly Diagnosed Patients Benzinga

01:04AM EST Regeneron : Phase 3 Results Show Dupixen Improved Skin Clearance In Children With Moderate-to-severe Atopic Dermatitis RTTNews

Dec 1, 2021

08:41AM EST The Daily Biotech Pulse: Adcom Backs Merck's Oral COVID-19 Treatment; Regulatory Setbacks For CTI Biopharma, BioXcel; Favorable Ruling For Viatris In Tecfidera Patent Case Benzinga

08:36AM EST The Daily Biotech Pulse: Adcom Backs Merck's Oral COVID-19 Treatment, Regulatory Setbacks For CTI Biopharma, Favorable Ruling For BioXcel, Viatris In Tecfidera Patent Case Benzinga

06:36AM EST Sanofi Adds Acne Vaccine Candidate Via Origimm Biotechnology Acquisition Benzinga

05:10AM EST Japan Confirmed Second Case of Omicron Variant of the Covid-19 on Wednesday Benzinga

05:09AM EST Sanofi Confirmed Vaccines Mid-term Guidance of Mid-to-high Single-digit Sales Growth, Ambition to More Than Double Vaccines Sales by the End of the Decade at Investor Event Benzinga

05:07AM EST Sanofi Announced Agreement to Acquire Austria's Origimm Biotechnology; Terms Not Disclosed Benzinga

Nov 30, 2021

09:11AM EST Sanofi Offers All Employees Worldwide 14 Weeks Paid Parental Leave RTTNews

09:06AM EST Sanofi offers all employees worldwide 14 weeks paid parental leave to ensure PR Newswire

Nov 22, 2021

10:24AM EST Baidu Licenses Its Algorithm To Sanofi For mRNA Vaccine, Therapy Development Benzinga

07:11AM EST Baidu Enters Into License Agreement With Sanofi To Enable Next-Generation mRNA Therapeutics And Vaccines Benzinga

Nov 19, 2021

08:20AM EST The Daily Biotech Pulse: Connect Biopharma Sinks On Eczema Drug Readout, Enanta Pulls Plug On HBV Drug, Clinical Setback For Merck In HIV Trial Benzinga

Nov 10, 2021

05:48AM EST Sanofi Said to Pick BofA, BNP Paribas and JPMorgan as Leads for Ingredients IPO Benzinga

Oct 29, 2021

08:00AM EDT The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs Benzinga

07:19AM EDT Sanofi's Libtayo Approved In Canada For Locally Advanced Basal Cell Carcinoma Patients Benzinga

07:19AM EDT Libtayo Approved In Canada For Locally Advanced Basal Cell Carcinoma Patients Benzinga

07:07AM EDT Sanofi Canada Says Libtayo Approved In Canada For Locally Advanced Basal Cell Carcinoma Patients RTTNews

Oct 28, 2021

06:58AM EDT Sanofi Raises FY21 Earnings Outlook As Dupixent, Vaccines Boost Q3 Performance Benzinga

04:08AM EDT Earnings Scheduled For October 28, 2021 Benzinga

Oct 25, 2021

11:18AM EDT Regeneron Early Monday Morning Announced Phase 3 Results From Trial Assessing Investigational Use Of Co.'s Dupixent In Patients 12+ With Eosinophilic Esophagitis Benzinga

01:04AM EDT Regeneron, Sanofi Announce Second Phase 3 Trial Of Dupixent Meets Co-primary Endpoints In Eosinophilic Esophagitis RTTNews

Oct 24, 2021

11:45AM EDT The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More Benzinga

Oct 22, 2021

07:36AM EDT The Daily Biotech Pulse: Athira CEO Resigns Over Doctored Research, Merck's Keytruda Snags First Approval For Breast Cancer In Europe, Minerva And Xilio IPOs Benzinga

01:01AM EDT Regeneron : Dupixent Significantly Reduced Itch At 12 Weeks RTTNews

Oct 21, 2021

12:11PM EDT The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO Benzinga

12:11PM EDT Regeneron, Sanofi Report FDA Expands Approval Of Dupixent To Include Children 6-11 Years With Moderate-To-Severe Asthma Benzinga

Oct 20, 2021

11:52AM EDT Sanofi, In CDC Presentation, Says Study Results Demonstrate That Its Flue Vaccine And Moderna's COVID-19 Vaccine Can Be Administered Safely, Supporting Existing Co-Administration Recommendations Benzinga

Oct 18, 2021

09:17AM EDT Benzinga Pro's Top 5 Stocks To Watch For Monday, Oct. 18, 2021: COIN, REGN, CLAR, ENFN, PTLO Benzinga

07:34AM EDT The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs Benzinga

Oct 13, 2021

06:15AM EDT Sanofi Canada Announces Health Canada Approval Of SARCLISA In Combination With Carfilzomib And Dexamethasone In Relapsed And/Or Refractory Multiple Myeloma Benzinga

Oct 7, 2021

04:31PM EDT Mirati Therapeutics Reports Collab With Sanofi For Phase 1/2 Study Evaulating Combo Of Adagrasib With SHP2 Inhibitor In KRAS G12C-Mutated Lung Cancer Benzinga

08:24AM EDT The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results Benzinga

06:52AM EDT Denali Highlights Encouraging Early Data, Update For Amyotrophic Lateral Sclerosis Program Benzinga

Oct 6, 2021

04:03PM EDT UPDATE: Denali Says Sanofi Will Begin Phase 2 Study For Amyotrophic Lateral Sclerosis In Q1'22 Benzinga

Oct 1, 2021

02:29PM EDT Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates Benzinga

Sep 28, 2021

08:18AM EDT The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive Benzinga

08:16AM EDT The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK To Develop Long-Acting HIV Treatments Benzinga

07:53AM EDT Sanofi Stops Work On Its mRNA COVID-19 Vaccine: What You Need To Know Benzinga

02:53AM EDT Sanofi Reports Positive Interim Results From Phase 1/2 Study Of MRNA-based COVID-19 Vaccine Candidate RTTNews

Sep 27, 2021

12:01PM EDT Analyst Upgrades Sanofi On COVID-19 Vaccine Optimism Benzinga

10:04AM EDT Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2021 Benzinga

07:14AM EDT SVB Leerink Upgrades Sanofi to Outperform Benzinga

05:53AM EDT Acceleron In Advanced $11B Buyout Talks: Bloomberg Benzinga

Sep 21, 2021

07:46PM EDT Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kadmon Holdings, Inc. - KDMN PR Newswire

Sep 20, 2021

06:45AM EDT Sanofi, Regeneron, Share Competitive Libtayo Survival Data in 1L NSCLC Benzinga

06:45AM EDT Regeneron Pharmaceuticals And Sanofi On Sunday Announced Phase 3 Results For A Libtayo Combination Treatment; Co. Reported 'Phase 3 trial met its primary and key secondary endpoints' Benzinga

Sep 12, 2021

04:04PM EDT The Week Ahead In Biotech (Sept. 12-18): Calliditas FDA Decision, Adcom Review For Pfizer/BioNTech COVID-19 Vaccine, Oncology Conference And IPOs Benzinga

Sep 9, 2021

10:04AM EDT Sanofi's BTK Inhibitor Disappoints In Phase 3 Autoimmune Disease Trial Benzinga

08:17AM EDT The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization Benzinga

Sep 8, 2021

06:30AM EDT Sanofi's $1.9 Billion Bet On Kadmon: What You Need to Know Benzinga

05:14AM EDT Sanofi to Acquire Kadmon for $9.50/Share in Cash Benzinga

Aug 31, 2021

07:12AM EDT Glaxo, SK Bioscience Start COVID-19 Vaccine Trial Against AstraZeneca Shot Benzinga

Aug 30, 2021

10:59AM EDT Pfizer's Abrocitinib Beats Dupixent Late-stage Eczema Trial Benzinga

06:59AM EDT Dupixent Becomes First Biologic To Show Benefit In Infant Patients With Atopic Dermatitis Benzinga

01:02AM EDT Regeneron Pharma, Sanofi Announce Phase 3 Results Of Dupixent Meets All Primary And Secondary Endpoints RTTNews

Aug 20, 2021

02:34PM EDT House Committee Questions Eli Lilly, Sanofi, Novo Nordisk On 'Unacceptably High' Insulin Prices Benzinga

Aug 17, 2021

01:44PM EDT Roche's Arthritis Drug, Used As COVID-19 Treatment, Faces Supply Shortage Benzinga

Aug 16, 2021

04:19PM EDT Inside Sanofi's $3.2B Translate Bio Buyout Benzinga

Aug 9, 2021

11:07AM EDT The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight Benzinga

Aug 6, 2021

12:31PM EDT FDA Approves Sanofi's Enzyme Therapy For Late-Onset Pompe Disease Benzinga

11:45AM EDT Sanofi Press Release Confirms Earlier Report FDA approves Nexviazyme (avalglucosidase alfa-ngpt), an important new treatment option for late-onset Pompe disease Benzinga

10:40AM EDT FDA Approves New Treatment For Pompe Disease, Says Granted Approval Of Nexviazyme To Genzyme Corporation For Treatment Of Pompe Disease Benzinga

Aug 5, 2021

08:08AM EDT The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO Benzinga

06:19AM EDT Regeneron Pharma And Sanofi: Phase 3 Trial Of Libtayo Combined With Chemotherapy Stopped Early RTTNews

Aug 4, 2021

07:52AM EDT The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings Benzinga

Aug 3, 2021

02:31PM EDT Mid-Afternoon Market Update: Dow Jumps Over 200 Points; Neuronetics Shares Plunge Benzinga

07:55AM EDT The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business Benzinga

05:03AM EDT Sanofi Announced it Will Acquire Translate Bio for $38/Share in Cash Benzinga

Aug 2, 2021

06:10PM EDT Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates Benzinga

Jul 29, 2021

08:18AM EDT The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs Benzinga

07:19AM EDT Sanofi Q2 Performance Benefits From Dupixent, Vaccines; Raises 2021 Profit Forecast Benzinga

07:06AM EDT Regeneron - Sanofi's Dupixent Improves Itch, Hives In Inflammatory Skin Disease Patients Benzinga

04:23AM EDT Earnings Scheduled For July 29, 2021 Benzinga

01:03AM EDT Regeneron, Sanofi: Phase 3 Trial On Dupixent In Patients With Chronic Spontaneous Urticaria Met Endpoints At 24 Weeks RTTNews

Jul 27, 2021

02:49PM EDT Sanofi's Pompe Disease Enzyme Replacement Therapy Gets EMA's CHMP Backing Benzinga

01:36PM EDT Sanofi Offers Update On EU Submission For Avalglucosidase Alfa: Says CHMP Adopted Positive Opinion Benzinga

Jul 26, 2021

10:03AM EDT UPDATE: Roth On Translate Bio: Firm Highlights Revolution Of mRNA Vaccine Technology; Notes Co. Has 1/3 Of R&D Funds Devoted To mRNA Vaccines With Sanofi Along With 10% Of Total Potential Revenues From Any Of The Possible Six Vaccines From Collaboration Benzinga

Jul 22, 2021

01:22PM EDT Sanofi-Regeneron's COPD Drug Fails In Mid-Stage Trial, But Shows Potential Benefit In Subgroup of Former Smokers Benzinga

Jul 20, 2021

02:32PM EDT EMA Starts Rolling Review Of Glaxo - Sanofi COVID-19 Vaccine Benzinga

10:02AM EDT European Medicines Agency Says Starts Rolling Review Of Sanofi COVID-19 Vaccine VIDPREVTYN Benzinga

Jul 19, 2021

01:19PM EDT Sanofi's Oral Treatment For Sleeping Sickness Gets FDA Approval Benzinga

Jul 8, 2021

09:19AM EDT Sanofi, GSK Get Nod For Late-Stage COVID-19 Vaccine Trial In India Benzinga

Jul 7, 2021

11:47AM EDT WHO Recommends IL-6 Drugs From Sanofi, Roche For Critically-Ill COVID-19 Patients Benzinga

09:14AM EDT SRI Enters Drug Discovery And Research Collaboration With Sanofi RTTNews

Jul 6, 2021

02:30PM EDT Sanofi Bets Over $1B For Eureka's Multiple Myeloma Candidate Benzinga

Jun 29, 2021

09:09AM EDT Sanofi Invests To Build Internal Capabilities in mRNA Benzinga

08:25AM EDT Watching Insulin Manufacturers After Walmart Announces Private Brand Analog Insulin Benzinga

08:17AM EDT The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout Benzinga

Jun 28, 2021

02:16PM EDT Sanofi Divests 16 Consumer Health Brands To Stada Benzinga

12:40PM EDT Sanofi's Soliqua Shows Improved Blood Sugar Control Without Weigh Gain Against Premixed Insulin Benzinga

10:27AM EDT A Look Into Healthcare Sector Value Stocks Benzinga

08:33AM EDT AstraZeneca's Nirsevimab Shows Favorable Safety, Tolerability Profile In Infants At High Risk Of RSV Benzinga

05:40AM EDT Regeneron's and Sanofi's Dupixent SmPC Updated With Long-term Data Reinforcing Well-established Safety Profile in Adults With Moderate-to-severe Atopic Dermatitis Benzinga

01:10AM EDT Regeneron Pharma And Sanofi: European Medicines Agency To Update Dupixent SmPC Adding Long-term Safety Results RTTNews

Jun 25, 2021

08:51AM EDT Sanofi - Regeneron's Immunotherapy Scores European Approval For Skin And Lung Cancer Settings Benzinga

07:32AM EDT The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs Benzinga

05:40AM EDT Regeneron Pharmaceuticals and Sanofi Announced Libtayo Approved by the European Commission as the First Immunotherapy Indicated for Patients with Advanced Basal Cell Carcinoma Benzinga

01:02AM EDT Regeneron And Sanofi: Libtayo Approved By European Commission For First-Line Treatment Of Patients With NSCLC RTTNews

Jun 22, 2021

08:12AM EDT The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal Benzinga

06:32AM EDT Sanofi, Translate Bio Initiate Early-Stage mRNA Influenza Vaccine Trial Benzinga

Jun 21, 2021

10:18AM EDT 5 Value Stocks To Watch In The Healthcare Sector Benzinga

06:04AM EDT Europe Approves Sanofi's Expanded Use Of Aubagio In Pediatric Patients With Multiple Sclerosis Benzinga

Jun 18, 2021

09:47AM EDT Sanofi Shares On Watch; European Commission Approves Aubagoi As First Oral MS Therapy For First-Line Treatment Of Children And Adolescents Living With Relapsing-Remitting Multiple Sclerosis Benzinga

07:08AM EDT BioNTech Starts Dosing In Mid-Stage Melanoma Vaccine Trial Benzinga

Jun 17, 2021

02:00PM EDT Sanofi Scores FDA Approval For Flu-Shot Facility In US Benzinga

Jun 11, 2021

02:32PM EDT Sanofi's Sutimlimab Hits Endpoint Goal In Rare Anemia Study After FDA Rejection Benzinga

Jun 7, 2021

02:10PM EDT Elevation Oncology Files for $100M IPO Benzinga

Jun 4, 2021

10:11AM EDT Sanofi Inks Partnership for Late-Stage Trial of Amcenestrant as Add-On Breast Cancer Therapy Benzinga

09:39AM EDT The Daily Biotech Pulse: Merck, AstraZeneca, Novartis Among Early Presenters At ASCO, Sanofi Strikes Breast Cancer Study Pact Benzinga

01:02AM EDT Sanofi Announces Partnership To Initiate Pivotal Trial Of An Oral SERD In The Adjuvant Setting RTTNews

01:00AM EDT amcenestrant in the adjuvant setting for patients with estrogen receptor positive breast cancer PR Newswire

Jun 3, 2021

11:15AM EDT White House Says Will Allocate ~19M COVID-19 Vaccine Doses To Be Shared Through Covax Benzinga

08:02AM EDT Diversifying to Conquer: Fortress Biotech (FBIO) Partnering Expansion Driving Progress in Cancer Immunotherapy and Rare Disease Therapeutics Benzinga

Jun 1, 2021

10:10AM EDT P/E Ratio Insights for Sanofi Benzinga

08:54AM EDT Sanofi Stops Venglustat Development In Rare Genetic Kidney Disorder Benzinga

06:48AM EDT Sanofi And Merck's Six-in-one Pediatric Combination Vaccine Vaxelis Now Available In US RTTNews

06:45AM EDT Sanofi and Merck's first and only six-in-one pediatric combination vaccine now PR Newswire

May 27, 2021

08:24AM EDT The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs Benzinga

08:07AM EDT Sanofi, GSK Start Final Testing Phase Of COVID-19 Vaccine Benzinga

May 25, 2021

08:05AM EDT Sanofi, Walvax COVID-19 Vaccine Phase 3 Trials to Commence in Mexico: Reuters Benzinga

May 24, 2021

03:20PM EDT Mexico Foreign Minister Says Mexico To Hose Phase Three Trials For Sanofi COVID-19 Vaccine Benzinga

08:11AM EDT Regeneron-Sanofi's Libtayo Scores CHMP's Positive Opinion For Two Advanced Cancer Settings Benzinga

05:23AM EDT Regeneron and Sanofi Announced Libtayo Received Positive CHMP Opinion for the Treatment in Europe of Two Advanced Cancers Benzinga

01:04AM EDT Regeneron And Sanofi Announce EMA CHMP Adopted Positive Opinions For Libtayo As Monotherapy In Two Advanced Cancers RTTNews

May 20, 2021

09:26AM EDT Eli Lilly's Tirzepatide Non-Inferior To Titrated Insulin Glargine In Type 2 Diabetes Patients Benzinga

May 18, 2021

06:30AM EDT GlaxoSmithKline-Medicago's COVID-19 Vaccine Candidate Elicit Strong Immune Response Benzinga

May 17, 2021

04:30PM EDT Sanofi-Regeneron Tout New Data For Dupixent From Pediatric Asthma Trial Benzinga

10:07AM EDT Regeneron : Pivotal Data Show Dupixent Significantly Reduced Asthma Attacks And Improved Lung Function In Children RTTNews

10:04AM EDT Sanofi Says Pivotal Data At ATS 2021 Show Dupixent 'Significantly Reduced Asthma Attacks And Improved Lung Functions In Children' Benzinga

09:45AM EDT A Look Into Healthcare Sector Value Stocks Benzinga

08:42AM EDT Benzinga Pro's Top 5 Stocks To Watch For Monday, May 17, 2021: WMT, DISCA, SQSP, SNY, TGT Benzinga

07:07AM EDT Sanofi-GSK's COVID-19 Vaccine Candidate Reports Success In Mid-Stage Study Benzinga

May 13, 2021

01:41PM EDT 5 Value Stocks In The Healthcare Sector Benzinga

May 12, 2021

09:44PM EDT 15 European Dividend Aristocrats To Diversify Your Portfolio Benzinga

08:57AM EDT The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron Benzinga

May 11, 2021

04:46PM EDT Cellectis And Sanofi Enter Partnership And Supply Agreement For Alemtuzumab; Financial Details Not Disclosed Benzinga

04:30PM EDT Cellectis and Sanofi partner on alemtuzumab as GlobeNewswire Inc

May 10, 2021

04:44PM EDT FDA Outlines Plan For Restarting Facility Inspections Halted Due To Pandemic Benzinga

09:43AM EDT 5 Value Stocks In The Healthcare Sector Benzinga

May 6, 2021

09:10AM EDT Regeneron Reports Mixed Bag On Q1 Earnings; Eylea Franchise Boosts Revenue Benzinga

07:49AM EDT The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom Benzinga

01:07AM EDT Sanofi Enters Three-year Research Collaboration With Stanford University School Of Medicine RTTNews

01:00AM EDT Sanofi establishes three-year collaboration with Stanford Medicine to PR Newswire

May 4, 2021

05:17PM EDT Sanofi Exec Roman Chicz Says Expect To Start Global Late-stage Study Of COVID-19 Vaccine In Q2; File Regulatory Submissions In 2H 2021 Benzinga

May 3, 2021

03:45PM EDT Sanofi shares were trading lower as the stock reached its ex-dividend date Monday. Benzinga

09:42AM EDT Avrobio Plans Registration Trial With Kidney Biopsy Endpoint To Support Potential Full Approval Of Fabry Disease Gene Therapy Benzinga

Apr 29, 2021

08:26AM EDT Moderna Tries To Boost COVID-19 Vaccine Supply Chain To Produce 3B Doses Annually Benzinga

Apr 28, 2021

01:29PM EDT Sanofi Shares Rise On Q1 Sales Boosted By Dupixent Franchise; Plans To Restart Haemophilia Study With Fitusiran Benzinga

11:19AM EDT Sanofi Earlier Reported Q1 EPS $1.94 Beats $0.78 Estimate, Sales $10.36B Miss $10.43B Estimate Benzinga

07:26AM EDT The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping Benzinga

Apr 26, 2021

10:34AM EDT Big Earnings Week Ahead To Close April In Style Benzinga

09:18AM EDT Sanofi Steps In For Fill-Finish 200M Doses Of Moderna's COVID-19 Vaccine Benzinga

07:12AM EDT Sanofi To Manufacture Up To 200 Mln Doses Of Moderna's Vaccine In The U.S. Starting In September 2021 RTTNews

07:01AM EDT Moderna Reports Deal With Sanofi To Fill/Finish Sterile Manufacturing Services, Supply Packaging For Up To 200M Doses Of Moderna's COVID-19 Vaccine In US Beginning In Sept 2021 Benzinga

07:01AM EDT Sanofi to help manufacture Moderna COVID-19 vaccine, supporting global supply PR Newswire

06:16AM EDT Sanofi-AstraZeneca's Nirsevimab Hits Primary Endpoint Goal In Late-Stage RSV Disease In Infants Benzinga

Apr 23, 2021

10:07AM EDT Sanofi Highlights Analysis For Dupixent Reinforcing Long-Term Safety, Efficacy Profile In Patients With Atopic Dermatitis As Young As 6 Years Benzinga

Apr 21, 2021

11:15AM EDT BioNTech CFO Sees Scope For Additional Production Sites To Meet Demand For COVID-19 Shots: Reuters Benzinga

Apr 19, 2021

05:17AM EDT Kazia Therapeutics Announced Worldwide Exclusive Licensing Deal & Master Services Deal With Evotec SE Benzinga

01:05AM EDT Sanofi: EC Approves Sarclisa In Combination With Carfilzomib And Dexamethasone For Relapsed Multiple Myeloma RTTNews

Apr 13, 2021

05:50AM EDT Sanofi Declares Offer for Kiadis Unconditional; 95.03% of Kiadis Shares in Total Committed Under the Offer Benzinga

Apr 12, 2021

10:44AM EDT Sanofi Earlier Announced Will Invest 400M Over 5 Years To Create Vaccine Production Center In Singapore Benzinga

10:29AM EDT 5 Value Stocks To Watch In The Healthcare Sector Benzinga

Apr 7, 2021

07:09AM EDT Sanofi Outlines Several Key Projects To Increase The Impact Of Corporate Social Responsibility Strategy RTTNews

07:01AM EDT Sanofi expands its social commitments, creates nonprofit unit to provide PR Newswire

Apr 1, 2021

07:46AM EDT The Daily Biotech Pulse: Pfizer-BioNTech Preps For BLA Filing, Sonoma Surges, BioXcel Readout, Ortho Clinical Lands Contract Benzinga

07:17AM EDT Sonoma Pharma Stock Is Trading Higher After Distribution Pact With EMC Pharma Benzinga

Mar 31, 2021

06:14PM EDT FDA approves Sarclisa(r) (isatuximab-irfc) in combination with carfilzomib and PR Newswire

05:18PM EDT Sanofi Announces That The FDA Approved Its Sarclisa Benzinga

02:26PM EDT Daiichi Axes Sanofi Vaccine Pact After Pertussis Jab Manufacturing Faces Snag Benzinga

11:57AM EDT Canadian Government, Sanofi To Build C$925M Flu Vaccine Facility In Toronto Benzinga

10:10AM EDT Sanofi Announces Investment Of More Than 600 Mln To Build New Vaccine Facility In Toronto RTTNews

10:07AM EDT UPDATE: Sanofi Expects New Facility To Be Operational In 2026 Following Design, Construction, Testing, Qualification Of Facility, Equipment Benzinga

10:07AM EDT Sanofi Announces Investment Of Over 600M To Build A New Vaccine Facility In Toronto; Co Expects New Facility To Be Operational In 2026 Benzinga

Mar 26, 2021

12:42PM EDT GlaxoSmithKline, Vir Biotechnology Seek Emergency FDA Authorization For COVID-19 Drug Benzinga

Mar 23, 2021

11:51AM EDT Pfizer Plans To Develop New mRNA-Based Vaccines By Itself, Says CEO: WSJ Benzinga

Mar 22, 2021

09:49AM EDT 5 Value Stocks To Watch In The Healthcare Sector Benzinga

Mar 19, 2021

09:31AM EDT Janssen's Ponvory Wins FDA Nod For Relapsing Multiple Sclerosis Benzinga

Mar 16, 2021

11:09AM EDT GSK Kick Starts Late-Stage Study With Medicago-Partnered COVID-19 Vaccine Benzinga

09:19AM EDT GBT In-Licenses Two Sickle Cell Disease Programs From Sanofi Benzinga

Mar 15, 2021

02:01PM EDT IDT Biologika To Make J&J's COVID-19 Vaccine Using Takeda's Manufacturing Capacity Benzinga

06:41AM EDT Regeneron/Sanofi Boast Positive Overall Survival Results In Late-Stage Cervical Cancer Study Benzinga

02:03AM EDT Regeneron Pharma, Sanofi Announce Positive Results Demonstrating Overall Survival Benefit From Phase 3 Trial Of Libtayo RTTNews

Mar 12, 2021

07:36AM EST The Daily Biotech Pulse: Novavax Vaccine Data, ContraFect Secures BARDA Funding, 2 IPOs Benzinga

05:59AM EST Sanofi, Translate Bio Initiate Human Trial Of mRNA COVID-19 Vaccine Candidate Benzinga

Mar 8, 2021

09:27AM EST Apple's Long-Rumored Mixed Reality Headset To Launch In 2022: Analyst Benzinga

Mar 5, 2021

03:42PM EST Three Ways To Approach The Cannabis Trade Benzinga

Mar 4, 2021

09:20AM EST News From The Vaccine World Benzinga

08:12AM EST The Daily Biotech Pulse: FDA Nod For Pfizer, Kiniksa Rises On Commercialization Pact With Regeneron, Bio-Techne To Buy Diagnostic Company Benzinga

08:08AM EST Sanofi/Regneron's Dupixent Application For Asthma In Children Accepted For FDA Review Benzinga

01:01AM EST Regeneron, Sanofi Announce FDA Accepted For Review SBLA For Dupixent For Children With Moderate-to-severe Asthma RTTNews

Mar 2, 2021

09:13AM EST Merck To Offer Hand With JNJ COVID-19 Vaccine Production, Biden Administration Says: Report Benzinga

Feb 23, 2021

11:33AM EST Sanofi/Regeneron's DUPIXENT Wins Canada Approval For Atopic Dermatitis In Children Aged 6-11 Benzinga

10:03AM EST Health Canada Approves Dupixent As First Biologic For Treatment Of Moderate-To-Severe Atopic Dermatitis In Children Aged 6-To-11 Years Benzinga

07:18AM EST FDA Approves Regeneron/Sanofi's Libtayo For Front-Line Lung Cancer Benzinga

06:40AM EST FDA Says Conduct Smaller Trials To Test Vaccine Efficacy Against COVID Variants Benzinga

Feb 22, 2021

01:02PM EST UPDATE: Regeneron, Sanofi Report 'Libtayo was superior in extending overall survival compared to chemotherapy in a pivotal trial...' Benzinga

01:02PM EST Regeneron, Sanofi Report FDA Approves Libtayo As Monotherapy for Patients with First-line Advanced Non-small Cell Lung Cancer with PD-L1 Expression of 50% Benzinga

06:07AM EST Sanofi Announces it Will Provide Manufacturing Support to Johnson & Johnson for Their Covid-19 Vaccine to Help Address Global Supply Demands Benzinga

05:46AM EST Sanofi, GSK Announced Initiation of New Phase 2 Study of Their Adjuvanted Recombinant Protein-based Covid-19 Vaccine Candidate Benzinga

Feb 16, 2021

01:24PM EST Bristol-Myers, Sanofi Fined $834M In Hawaii Over Plavix: Bloomberg Benzinga

Feb 12, 2021

06:01AM EST Sanofi Offers Cash Buyout For Kiadis Benzinga

05:45AM EST Sanofi Launched Recommended Cash Offer for All Shares in Kiadis Benzinga

Feb 11, 2021

05:07PM EST US Federal Circuit Court Of Appeals Rules In Favor Of Regeneron And Sanofi In Praluent Patent Litigation; Court Upheld Decision That Amgen's Asserted Patent Claims Toward PCSK9 Are Invalid Benzinga

Feb 10, 2021

08:13AM EST I2O Therapeutics Announces Research Collaboration With Sanofi To Enable Oral Delivery Of Nanobody-Based Medicines Benzinga

07:34AM EST The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs Benzinga

05:24AM EST Sanofi/Regeneron's Libtayo Wins FDA Approval For A Type Of Skin Cancer Benzinga

Feb 9, 2021

05:26PM EST Regeneron, Sanofi: FDA Approves Libtayo As First Immunotherapy Indicated For Patients With Advanced BCC RTTNews

05:17PM EST Sanofi Says FDA Approves Libtayo As 'First Immunotherapy Indicated For Patients With Advanced Basal Cell Carcinoma' Benzinga

Feb 8, 2021

02:24PM EST A Look Into Sanofi's Price Over Earnings Benzinga

08:25AM EST A Look Into Sanofi's Debt Benzinga

Feb 5, 2021

11:05AM EST Sanofi Swings To Fourth Quarter Profit Despite Lower Sales; Expands Cost-Savings Push By 500M Benzinga

09:59AM EST Sanofi CEO: Share Buybacks Are 'Low' On The Priority List Benzinga

08:09AM EST Regeneron's Q4 Double-Digit Top and Bottom-Line Growth Propelled By Higher Sales From Eylea And Dupixent Benzinga

07:57AM EST Sanofi: Q4 Earnings Insights Benzinga

07:44AM EST The Daily Biotech Pulse: J&J Files For COVID-19 Vaccine Approval, Zimmer Biomet's Spin-Off, IPO Deluge Hits Street Benzinga

07:15AM EST Sanofi Swings To Forth Quarter Profit Despite Lower Sales; Expands Cost-Savings Push By 500M Benzinga

03:36AM EST Earnings Scheduled For February 5, 2021 Benzinga

Feb 3, 2021

02:07PM EST Pfizer Is Ready, Even For COVID-19 Variants Benzinga

Feb 1, 2021

11:37AM EST A Preview Of The Busy Earnings Week Ahead Benzinga

Jan 31, 2021

05:22AM EST Attention Biotech Investors: Mark Your Calendar For February PDUFA Dates Benzinga

Jan 29, 2021

03:52PM EST Breaking Down Novavax's Coronavirus Vaccine Data: 2 Analyst Takes Benzinga

Jan 27, 2021

07:36AM EST The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement Benzinga

05:02AM EST Sanofi To Manufacture 125 Million COVID-19 Vaccine Doses For Rival Pfizer-BioNTech Benzinga

Jan 26, 2021

12:06PM EST Sanofi Will Supply More Than 100M Of Pfizer Vaccine Doses By The End Of The Year Benzinga

Jan 25, 2021

04:01PM EST Nanobiotix's Curadigm Subsidiary Reports New Collaboration Deal With Sanofi Benzinga

09:49AM EST 5 Value Stocks In The Healthcare Sector Benzinga

Jan 19, 2021

10:27AM EST Senate Finance Committee Ranking Member Wyden Says Wants To See Fresh Investigation Of Big Pharmaceutical 'Price Gouging Schemes' On Insulin Benzinga

Jan 15, 2021

11:39AM EST Deutsche Bank Initiates Coverage On Sanofi with Sell Rating Benzinga

document.getElementById("NP0JXM").onerror = function(){this.style.display='none';}; .dark-mode .xfJqZJ{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .xfJqZJ{ color: #333333; background-color: white; border: 2px solid #333333; }SNYSanofistock NASDAQ ADR

SNY
Sanofi
stock NASDAQ ADR